11/25
01:58 pm
uncy
Unicycive Therapeutics (NASDAQ:UNCY) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings .
Low
Report
Unicycive Therapeutics (NASDAQ:UNCY) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings .
11/25
08:01 am
uncy
Unicycive Therapeutics to Participate in Upcoming Investor Events in December [Yahoo! Finance]
Low
Report
Unicycive Therapeutics to Participate in Upcoming Investor Events in December [Yahoo! Finance]
11/25
07:05 am
uncy
Unicycive Therapeutics to Participate in Upcoming Investor Events in December
Medium
Report
Unicycive Therapeutics to Participate in Upcoming Investor Events in December
11/18
06:27 am
uncy
Retail investors who hold 48% of Unicycive Therapeutics, Inc. (NASDAQ:UNCY) gained 23%, institutions profited as well [Yahoo! Finance]
Low
Report
Retail investors who hold 48% of Unicycive Therapeutics, Inc. (NASDAQ:UNCY) gained 23%, institutions profited as well [Yahoo! Finance]
11/12
08:19 am
uncy
Unicycive Therapeutics GAAP EPS of -$0.46 beats by $0.07 [Seeking Alpha]
Medium
Report
Unicycive Therapeutics GAAP EPS of -$0.46 beats by $0.07 [Seeking Alpha]
11/12
07:35 am
uncy
Unicycive Therapeutics Announces Third Quarter 2025 Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
Unicycive Therapeutics Announces Third Quarter 2025 Financial Results and Provides Business Update [Yahoo! Finance]
11/12
07:05 am
uncy
Unicycive Therapeutics Announces Third Quarter 2025 Financial Results and Provides Business Update
Medium
Report
Unicycive Therapeutics Announces Third Quarter 2025 Financial Results and Provides Business Update
11/3
07:05 am
uncy
Unicycive Therapeutics to Participate in a Fireside Chat at the Guggenheim 2nd Annual Healthcare Innovation Conference
Medium
Report
Unicycive Therapeutics to Participate in a Fireside Chat at the Guggenheim 2nd Annual Healthcare Innovation Conference
11/14
06:34 pm
uncy
Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: Vivo Opportunity Fund Holdings, L.P.
Medium
Report
Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: Vivo Opportunity Fund Holdings, L.P.
11/14
05:10 pm
uncy
Form 8-K Unicycive Therapeutics, For: Nov 14
Medium
Report
Form 8-K Unicycive Therapeutics, For: Nov 14
11/14
05:09 pm
uncy
Form 424B5 Unicycive Therapeutics,
Medium
Report
Form 424B5 Unicycive Therapeutics,
11/14
04:53 pm
uncy
Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: Octagon Capital Advisors LP
Low
Report
Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: Octagon Capital Advisors LP
11/14
04:46 pm
uncy
Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: Nantahala Capital Management, LLC
Low
Report
Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: Nantahala Capital Management, LLC
11/14
04:26 pm
uncy
Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Low
Report
Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
11/14
03:02 pm
uncy
Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: GREAT POINT PARTNERS LLC
Low
Report
Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: GREAT POINT PARTNERS LLC
11/12
09:12 am
uncy
Form 8-K Unicycive Therapeutics, For: Nov 12
Medium
Report
Form 8-K Unicycive Therapeutics, For: Nov 12
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register